Infinity Pharmaceuticals (NASDAQ:INFI – Get Rating) announced its quarterly earnings results on Tuesday. The biotechnology company reported ($0.13) EPS for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.01, MarketWatch Earnings reports. Infinity Pharmaceuticals had a negative return on equity of 172.12% and a negative net margin of 2,398.81%. During the same period last […]
Wall Street analysts expect Infinity Pharmaceuticals, Inc. (NASDAQ:INFI – Get Rating) to report $410,000.00 in sales for the current quarter, according to Zacks. Five analysts have issued estimates for Infinity Pharmaceuticals’ earnings. The highest sales estimate is $550,000.00 and the lowest is $200,000.00. Infinity Pharmaceuticals reported sales of $440,000.00 in the same quarter last year, […]
Shares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI – Get Rating) have earned a consensus rating of “Buy” from the seven ratings firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the […]
NFI Group Inc. (TSE:NFI – Get Rating) Director Adam L. Gray bought 547,000 shares of the stock in a transaction dated Friday, March 18th. The shares were acquired at an average price of C$16.01 per share, for a total transaction of C$8,757,470.00. Following the completion of the transaction, the director now owns 8,537,387 shares of […]
NFI Group Inc. (TSE:NFI – Get Rating) Director Adam L. Gray purchased 100,000 shares of NFI Group stock in a transaction that occurred on Wednesday, March 23rd. The shares were bought at an average cost of C$16.47 per share, for a total transaction of C$1,647,000.00. Following the completion of the transaction, the director now directly […]